Last updated on September 2015

Lupus Nephritis


Brief description of study

Lupus Nephritis

Detailed Study Description

The drug being tested is called belimumab. It is a prescription medicine to treate active systemic lupus erythematosus who are receiving other lupus medicines. The purpose of the study is to find out if belimumab is effective and safe in treating patients with active lupus nephritis who are receiving other standard lupus nephritis medicines.

Clinical Study Identifier: TX141478

Contact Investigators or Research Sites near you

Start Over

Stephanie Hanzl

Northeast Clinical Research Center, LLC.
Bethlehem, PA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.